Bluefin Capital Management’s Tenet Healthcare THC Stock Holding History

Bluefin Capital Management’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-16,338	Closed	-$924K	–	689
2022 Q2	$924K	Buy	+16,338	New	+$1.14M	0.1%	143
2022 Q1	–	Sell	-393,646	Closed	-$32.2M	–	975
2021 Q4	$32.2M	Buy	393,646 +2,728	+0.7%	+$199K	2.24%	6
2021 Q3	$26M	Buy	390,918 +3,116	+0.8%	+$221K	2.58%	7
2021 Q2	$26M	Buy	387,802 +27,429	+8%	+$1.7M	1.65%	9
2021 Q1	$18.7M	Sell	360,373 -38,402	-10%	-$1.94M	0.87%	20
2020 Q4	$15.9M	Buy	+398,775	New	+$12.9M	0.93%	16
2020 Q3	–	Sell	-322,147	Closed	-$8.23M	–	24
2020 Q2	$5.83M	Buy	322,147 +42,209	+15%	+$832K	0.49%	28
2020 Q1	$4.03M	Buy	+279,938	New	+$8.04M	0.52%	40
2017 Q4	–	Sell	-84,419	Closed	-$1.39M	–	592
2017 Q3	$1.39M	Sell	84,419 -50,393	-37%	-$854K	0.16%	112
2017 Q2	$2.61M	Buy	+134,812	New	+$2.35M	0.28%	75

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

CCA

Canyon Capital Advisors Dallas, Texas $882M AUM 62.77% 1-Year Est. Return

Bluefin Capital Management's THC Position: Q3 2022 in Review

Bluefin Capital Management sold out of Tenet Healthcare (THC) in Q3 2022, closing a stake of 16,338 shares — an estimated $924K sold.

Bluefin Capital Management first reported a position in THC in Q2 2017 and held it in 10 quarters. The position peaked at $32.2M in Q4 2021. 360 funds tracked by Wall St. Rank hold THC as of Q3 2022.

Bluefin Capital Management reported no remaining Tenet Healthcare position as of Q3 2022 after selling out during the quarter.
Bluefin Capital Management sold 16,338 Tenet Healthcare shares in Q3 2022, an estimated $924K.
Bluefin Capital Management first reported a position in Tenet Healthcare in Q2 2017 and held it in 10 quarters.
Bluefin Capital Management's Tenet Healthcare position peaked at $32.2M in Q4 2021.
360 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2022.

Based on Bluefin Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.